Villanova di San Daniele, July 13, 2010 - Lima Corporate, the Italian orthopaedics and traumatology multinational and ÆQUOSTM, a German company specialised in the development and distribution of pioneering prosthetic designs, are pleased to announce the agreement by which Lima Corporate has acquired all ÆQUOSTM knee replacement patents, assets, technology and know- how. The agreement will allow Lima Corporate to boost the development of a new generation of knee arthroplasty solutions and become a leader in the knee replacement market segment alongside its highly successful hip and shoulder business units. The market for orthopaedic knee implants represents over 50% of global large joint revenues and is likely to continue to experience significant growth in the future.

ÆQUOS™ aimed to be ahead of this growing market by designing the “G1” prosthesis, which is based on the natural kinematics of the knee joint and “rolls and glides like the human knee”. Lima Corporate recognised the potential of this product, and in 2010 decided to acquire all of ÆQUOS™ knee-related activities to develop a cutting-edge knee replacement system designed around the needs of patients and surgeons: natural and pain-free motion, enhanced stability and control, rapid postoperative recovery, improved long-term implant durability and easy, accurate and reproducible surgical technique. Lima Corporate has always believed in the importance of co-operation and idea sharing to anticipate global customer demand; this latest project with ÆQUOSTM provides further evidence of this commitment. Caspar Graf Stauffenberg, the Managing Director of ÆQUOSTM, and his team will collaborate with Lima Corporate during the transition period to ensure effective knowledge transfer and continuity in product development.

About ÆQUOS

Aequos Endoprothetik GmbH is dedicated to the development and marketing of innovative joints, focusing in particular on joint prostheses for human patients. ÆQUOSTM was founded in 2005 by a group of renowned university scientists whose research focused on the biomechanics of human joints. ÆQUOSTM’ first marketable product is the G1 knee prosthesis, which has been clinically tested in various partner centres and has been on the market in Germany since 2005. The mission of ÆQUOSTM is to help people pursue a quality of life that knows no limits. ÆQUOSTM ́ innovative joint prostheses are designed to let patients enjoy the level of mobility and freedom from pain that they should expect at their age. ÆQUOSTM reaches this goal through prostheses that closely resemble the natural joint in form and function. The design encompasses the biomechanical principles of the natural joint and thus makes natural and acquired movements possible again.

For additional information on the Company, please visit: www.aequos.de